Small-molecule enhancement of METTL3 S-palmitoylation as a therapeutic strategy for osteoarthritis.

METTL3 undergoes S-palmitoylation, which promotes cytoplasmic phase separation to facilitate mRNA translation and maintain its stability. We identify a small molecule that enhances this modification, providing a mechanistic basis for a potential osteoarthritis therapy.